MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $118.1 million versus the consensus estimate of $106.94 million.

GUIDANCE:

MiMedx Group sees FY2026 revenue of $340-360 million, versus the consensus of $356.2 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.